research use only
Cat.No.S4546
| Related Targets | CXCR Nrf2 Mitophagy LRRK2 ULK FKBP Heme Oxygenase cGAS LC3 Cell wall |
|---|---|
| Other Autophagy Inhibitors | Resveratrol (trans-Resveratrol) Spautin-1 PIK-III DC661 Lys05 Autophinib Spermidine SMER28 EN6 Flubendazole |
|
In vitro |
DMSO
: 30 mg/mL
(197.17 mM)
Water : 30 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 152.15 | Formula | C5H12O5 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 87-99-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Adonitol, Ribitol, Xylite, D-Xylitol, Adonite | Smiles | C(C(C(C(CO)O)O)O)O | ||
| Targets/IC50/Ki |
angiogenesis
|
|---|---|
| In vitro |
Xylitol is reported to have an inhibitory effect on LPS-induced inflammatory cytokine expression. This compound strongly inhibits tube formation, migration, and invasion of HUVECs. It decreases the mRNA expression of key angiogenic molecules and their receptors (VEGF, KDR, bFGF and bFGFR-II) in a dose-dependent manner. Also, it suppresses NF-κB and Akt activation of HUVECs.
|
| In vivo |
Xylitol triggers the release of insulin in dogs and inhibits in vivo angiogenesis. It prominently inhibits the formation of neo-microvessels in the Matrigel assay, and reduces the hemoglobin content in the Matrigel plug.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT03229551 | Completed | Chronic Rhinosinusitis|Rhinosinusitis|Sinusitis|Drain Sinus|Endoscopic Sinus Surgery|Biofilms|Bacterial Overgrowth |
Ochsner Health System|Tulane University School of Medicine |
March 1 2018 | Phase 2|Phase 3 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.